Health Care/Hospital Global News & Press Release Distribution

Health Care/Hospital

All
APAC

I-Mab Announces Upcoming Participation at November Conferences

SHANGHAI, China, and GAITHERSBURG, MD., Oct. 28, 2020 /PRNewswire/ -- I-Mab (the "Company") (Nasdaq: IMAB), a clinical stage biopharmaceutical company committed to the discovery, development and commercialization of novel biologics, today announced its participation in the following conferences i...

2020-10-28 20:00 2758

Yiling Pharmaceutical: Revenue and Net Profit Attributable to the Parent Company for the First Three Quarters Already Exceeded the Full Year 2019

SHIJIAZHUANG, China, Oct. 28, 2020 /PRNewswire/ -- On October 27, Yiling Pharmaceutical (002603.SZ) released its 2020 third quarter report. In the first three quarters of the year, Yiling Pharmaceutical achieved the total operating revenue of6.447 billion yuan (about US$962 million), a 48.31% yea...

2020-10-28 17:04 6645

Daewoong Pharmaceutical's Long-Acting Niclosamide Shows High Promise Against Upcoming COVID-19 'Twindemic'

SEOUL, South Korea, Oct. 27, 2020 /PRNewswire/ -- Daewoong Pharmaceutical, a South Korean pharmaceutical giant announced that its Covid-19 treatment candidate of sustained-release niclosamide (DWRX2003) also showed promising study results for a fight against the upcoming 'Twindemic' involving COV...

2020-10-27 21:00 1307

VeChain, Renji Hospital and DNV GL Held Strategic Partnership Signing Ceremony To Launch World's First Blockchain Intelligent Tumor Treatment Center

SHANGHAI, Oct. 27, 2020 /PRNewswire/ -- In partnership with VeChain and DNV GL, Renji Hospital, a top-ranked hospital inChinaaffiliated with the Shanghai Jiaotong University School of Medicine, has announced the launch of the world's first blockchain-enabled Intelligent Tumor Treatment Center on ...

2020-10-27 21:00 2080

VeChain, Renji Hospital and DNV GL Held Strategic Partnership Signing Ceremony To Launch World's First Blockchain Intelligent Tumor Treatment Center

Genome & Company announces first patient dosed in Phase 1/1b study of GEN-001, an immuno-oncology microbiome therapeutic, in combination with avelumab

* The first microbiome oncology therapeutic candidate developed by an Asia -based biotech successfully initiatesphase 1/1b clinical trial in the US, six months after its IND went into effect. * The first patient enrolled and treated at OHSU (Oregon Health & Science University Knight Cancer In...

2020-10-27 21:00 1473

I-Mab to Present Preclinical Data of TJ210 at the 2020 Society for Immunotherapy of Cancer (SITC) Annual Meeting

SHANGHAI and GAITHERSBURG, Md., Oct. 27, 2020 /PRNewswire/ -- I-Mab (the "Company") (Nasdaq: IMAB), a clinical stage biopharmaceutical company committed to the discovery, development and commercialization of novel biologics, today announced that the Company will present the latest preclinical dat...

2020-10-27 20:05 4685

Alterity commences enrolling Multiple System Atrophy patients in bioMUSE Study

MELBOURNE, Australia and SAN FRANCISCO, Oct. 26, 2020 /PRNewswire/ -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) ("Alterity" or "the Company") today announced it has commenced enrolling patients with Multiple System Atrophy (MSA) in its bioMUSE Study inthe United States. BioMUSE is a natur...

2020-10-27 10:03 3688

USANA Malaysia named number one combination dietary supplements brand in the country by world-leading market research company

USANA Malaysia honored by Euromonitor International for second year in a row SALT LAKE CITY, Oct. 27, 2020 /PRNewswire/ -- To be recognized as the top company in your industry is an honor few achieve—one USANA Malaysia has earned for the second year in a row. USANA was recently named the No. 1 C...

2020-10-27 03:05 3277

Reistone Biopharma Announces Positive Topline Results from Phase 2 Clinical Trial Evaluating SHR0302, a JAK1 Inhibitor for the Treatment of Moderate-to-Severe Atopic Dermatitis

* SHR0302 monotherapy achieved positive results on reaching primary endpoints with statistical significance, delivering significant improvements in skin clearance * Both doses were shown to be superior to placebo for key secondary endpoints * AEs were manageable and generally transient and r...

2020-10-26 19:40 1460

GMAX Biopharm gives first does of anti-body drug treating PAH in phase 1B trial

HANGZHOU, China, Oct. 26, 2020 /PRNewswire/ -- Gmax Biopharm today announces that the first dose of GMA301 was given to the patient in its phase1B trial to investigate the drug efficacy to treat pulmonary arterial hypertension (PAH). GMA 301 is the first antibody drug for PAH treatment. In the ph...

2020-10-26 18:00 1507

New Data On Mayne Pharma's Tolsura® (SUBA®-itraconazole) Presented At IDWeek 2020

ADELAIDE, Australia, Oct. 26, 2020 /PRNewswire/ -- Mayne Pharma Group Limited (ASX: MYX) is pleased to announce that new clinical data has been presented on TOLSURA® (SUBA®-itraconazole) at IDWeek 2020, being held virtually in the US fromOctober 21st-25th. The conference is attended by over 11,50...

2020-10-26 12:10 3363

"World's Firsts" Catching Eyes at Asia's Largest Medical Equipment Exhibition

SHANGHAI, Oct. 24, 2020 /PRNewswire/ -- With the global pandemic at the forefront, the 83rd China International Medical Equipment Fair (CMEF 2020) marked the world's largest offline exhibition for the medical sector, attracting many leading players to showcase their latest developments in medica...

2020-10-24 21:22 2532

Lianluo Smart Limited Announces 1-for-8 Reverse Stock Split

BEIJING, Oct. 23, 2020 /PRNewswire/ -- Lianluo Smart Limited ("LLIT" or the "Company") (NASDAQ: LLIT), aChina based professional smart service and products provider, today announced that the Company has effected a one-for-eight (1-for-8) reverse stock split of Class A common shares, par value$0.0...

2020-10-23 20:30 13877

Frontliners Med Unveils the Support-95(TM) in Special Edition Warrior Pink

HONG KONG, Oct. 23, 2020 /PRNewswire/ -- Frontliners Med launches special edition warrior pink respirator to protect breast cancer warriors and their families. Proceeds will provide PPE donations and subsidized mental health services to COVID-19 healthcare workers and their families affected by b...

2020-10-23 20:15 2953

PharmAbcine to participate at BIO-Europe 2020

DAEJEON, South Korea, Oct. 23, 2020 /PRNewswire/ -- PharmAbcine Inc. (KOSDAQ: 208340ks) announced today that the company will participate in the 26th Annual International BIO-Europe Partnering Conference which will be held digitally from October 26th to 29th. PharmAbcine's business development ...

2020-10-23 20:00 10420

111 to Announce Third Quarter 2020 Unaudited Financial Results on November 19, 2020

SHANGHAI, Oct. 22, 2020 /PRNewswire/ -- 111, Inc. (NASDAQ: YI) ("111" or the "Company"), a leading digital healthcare platform committed to digitally connecting patients with healthcare products and services inChina, today announced that it will report its unaudited financial results for the thir...

2020-10-22 18:00 9418

Longevity Acquisition Corporation Announces Signing of Definitive Merger Agreement

SHANGHAI, Oct. 22, 2020 /PRNewswire/ -- Longevity Acquisition Corporation (NASDAQ: LOAC) (the "Company" or "LOAC"), a publicly-traded special purpose acquisition company (SPAC), announced that it has signed a definitive merger agreement with 4D pharma PLC (AIM: DDDD, "4D pharma" or "4D"). Upon co...

2020-10-22 14:00 9322

VolitionRx Limited Releases Video of Virtual Capital Markets Day 2020

AUSTIN, Texas, Oct. 21, 2020 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition") a multi-national epigenetics company developing simple, easy to use, cost effective blood tests to help diagnose a range of cancers and other diseases in both humans and animals, hosted a capital ma...

2020-10-21 20:00 9583

Samsung Biologics' strategic business operations continue to support strong third quarter earnings

INCHEON, South Korea, Oct. 21, 2020 /PRNewswire/ -- Samsung Biologics (KRX: 207940.KS) maintained steady financial results for its fiscal 2020 third quarter endingSeptember 30, demonstrating confident execution of its ongoing business operations. The Company recorded strong revenues of KRW 274.6...

2020-10-21 19:00 8228

AS Capital, Inc. Announces Corporate Name and Ticker Symbol Changes to Hanjiao Group, Inc. (HJGP)

BEIJING, Oct. 20, 2020 /PRNewswire/ -- AS Capital, Inc. (OTC Pink: ASIN), a Nevada corporation engaged in the selling of healthcare and other related products to the middle-aged and elderly market segments in the PRC through its online e-Commerce platform and offline service centers, today announ...

2020-10-21 07:55 6955

1 ... 250 251 252253254 255 256 ... 284

Week's Top Stories

dss⁺ Announces Strategic Changes to Executive Leadership Team in Asia Pacific Accelerating growth and impact for high-hazard industries in the region

[Picked up by 305 media titles]

2025-01-21 16:00

dss⁺ Announces Strategic Changes to Executive Leadership Team in Asia Pacific Accelerating growth and impact for high-hazard industries in the region

Infobip Research Unveils Opportunities for Brands to Engage Customers with Rich Communication Services (RCS) across APAC

[Picked up by 290 media titles]

2025-01-20 21:09